CN100482260C - Gout plaster - Google Patents
Gout plaster Download PDFInfo
- Publication number
- CN100482260C CN100482260C CNB2006100195931A CN200610019593A CN100482260C CN 100482260 C CN100482260 C CN 100482260C CN B2006100195931 A CNB2006100195931 A CN B2006100195931A CN 200610019593 A CN200610019593 A CN 200610019593A CN 100482260 C CN100482260 C CN 100482260C
- Authority
- CN
- China
- Prior art keywords
- gout
- carbuncle
- crude drug
- furuncle
- apply
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 201000005569 Gout Diseases 0.000 title claims abstract description 14
- 239000011505 plaster Substances 0.000 title claims description 7
- 239000003814 drug Substances 0.000 claims abstract description 13
- 229940079593 drug Drugs 0.000 claims abstract description 12
- 239000008517 radix Trichosanthis Substances 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 5
- 231100000614 poison Toxicity 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 9
- 239000002574 poison Substances 0.000 abstract description 9
- 206010007247 Carbuncle Diseases 0.000 abstract description 8
- 239000000203 mixture Substances 0.000 abstract description 5
- 230000006378 damage Effects 0.000 abstract description 3
- 230000008961 swelling Effects 0.000 abstract description 3
- 240000002853 Nelumbo nucifera Species 0.000 abstract description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- YFESOSRPNPYODN-RSMWSHJLSA-N (2s,3s,4s,5r,6r)-6-[[(4s,6ar,6bs,8r,8ar,9r,10r,14br)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(z)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3,5-bis[[(2s,3r,4s, Chemical compound O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)OC1CC[C@]2(C)C3CC=C4[C@@]([C@@]3(CCC2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(CC14)(C)C)OC(=O)C(\C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O.O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)OC1CC[C@]2(C)C3CC=C4[C@@]([C@@]3(CCC2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(CC14)(C)C)OC(=O)C(/C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YFESOSRPNPYODN-RSMWSHJLSA-N 0.000 abstract 1
- AXNVHPCVMSNXNP-GKTCLTPXSA-N Aescin Natural products O=C(O[C@H]1[C@@H](OC(=O)C)[C@]2(CO)[C@@H](O)C[C@@]3(C)[C@@]4(C)[C@@H]([C@]5(C)[C@H]([C@](CO)(C)[C@@H](O[C@@H]6[C@@H](O[C@H]7[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)[C@@H](O)[C@H](O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O7)[C@@H](C(=O)O)O6)CC5)CC4)CC=C3[C@@H]2CC1(C)C)/C(=C/C)/C AXNVHPCVMSNXNP-GKTCLTPXSA-N 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 240000007232 Illicium verum Species 0.000 abstract 1
- 235000008227 Illicium verum Nutrition 0.000 abstract 1
- 238000001784 detoxification Methods 0.000 abstract 1
- 235000012907 honey Nutrition 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 231100000572 poisoning Toxicity 0.000 abstract 1
- 230000000607 poisoning effect Effects 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 206010017553 Furuncle Diseases 0.000 description 6
- 238000005303 weighing Methods 0.000 description 4
- 241000244987 Daiswa polyphylla Species 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗痛风、痈肿疖毒的痛风膏，它由以下各相应重量数的原料药制成，八角莲8-12g、山药8-12g、七叶一枝花4-6g、伏苓8-12g、天花粉8-12g，本发明的制备方法是：按原料药的重量比称取各组分，将各组分研成细末，用蜂蜜调匀，外用。本发明的优点是：(1)搽涂使用方便；(2)消肿排毒效果好；(3)毒副作用，不会对人体正常组织产生破坏作用；(4)适用于治疗痛风、痈肿疖毒。A gout ointment for treating gout, carbuncle and furuncle poisoning, which is made of the following crude drugs with corresponding weights, 8-12g of star anise lotus, 8-12g of Chinese yam, 4-6g of aescin and 8-12g of Fuling , TCS 8-12g, the preparation method of the present invention is: take each component according to the weight ratio of crude drug, grind each component into fine powder, mix thoroughly with honey, and apply externally. The invention has the advantages of: (1) easy to apply and use; (2) good swelling and detoxification effect; (3) toxic and side effects, no damage to normal tissues of the human body; (4) suitable for treating gout, carbuncle and furuncle poison.
Description
Technical field
The present invention relates to a kind of gout plaster for the treatment of gout, carbuncle furuncle poison.
Background technology
People do not note taking good care of, QI and blood is prosperous excessively, often easily cause gout, grow various carbuncles, swollen, furuncle poison etc. in the local position of health, pain unbearably, influence is physically and mentally healthy, application number: 03118689.0 discloses a kind of " gout plaster ", and it has heat-clearing and toxic substances removing, reducing swelling and alleviating pain function, and carbuncle, swollen, furuncle are malicious a certain curative effect to curing, but have certain poison to pay effect, dosage is excessive to have destruction to human normal tissue.
Summary of the invention
The purpose of this invention is to provide a kind of gout plaster for the treatment of gout, carbuncle furuncle poison, put the affected part on the skin outside it, the part can not produce redness.
The present invention is achieved like this, it is made by the crude drug of following each corresponding weight number, Radix et Rhizoma Dysosmatis 8-12g, Rhizoma Dioscoreae 8-12g, Rhizoma Paridis 4-6g, Fu Ling 8-12g, Radix Trichosanthis 8-12g, preparation method of the present invention is: the weight ratio by crude drug takes by weighing each component, with each component pulverization, mix well external with Mel.In the present invention, eight usefulness lotuses have the detoxicating and resolving stagnation of pathogens function; Rhizoma Dioscoreae has the supplementing QI and nourishing YIN function; Rhizoma Paridis has heat-clearing and toxic substances removing, the reducing swelling and alleviating pain function; Poria has diuresis, spleen reinforcing, the effect of calming the nerves; Radix Trichosanthis has clearing away heat and promoting production of body fluid, the detumescence and apocenosis function.
Advantage of the present invention is: (1) put on the skin be coated with easy to use; (2) the detumescence effect of ejecting poison is good; (3) it is little that poison is paid effect, can not produce destruction to human normal tissue; (4) be applicable to treatment gout, carbuncle furuncle poison.
The specific embodiment
Embodiment one, take by weighing Radix et Rhizoma Dysosmatis 8g, Rhizoma Dioscoreae 8g, Radix Trichosanthis 8g, Poria 8g, Paris polyphylla 4g, above crude drug is ground respectively to smalls mixes, mix well, put the affected part outward on the skin with Mel by the weight ratio of crude drug.
Embodiment two, take by weighing Radix et Rhizoma Dysosmatis 10g, Rhizoma Dioscoreae 10, Radix Trichosanthis 10g, Poria 10g, Paris polyphylla 5g, above crude drug is ground respectively to smalls mixes, mix well, put the affected part outward on the skin with Mel by the weight ratio of crude drug.
Embodiment three, take by weighing Radix et Rhizoma Dysosmatis 12g, Rhizoma Dioscoreae 12g, Radix Trichosanthis 12g, Poria 12g, Paris polyphylla 6g, above crude drug is ground respectively to smalls mixes, mix well, put the affected part outward on the skin with Mel by the weight ratio of crude drug.
The gout plaster that adopts above crude drug to make is used through the clinical verification of Nanchang institute of traditional Chinese medicine, and carbuncle furuncle poison is had certain curative effect.
| Example number N | Recovery from illness N% | Produce effects N% | Effective N% | Invalid N% | Cure-remarkable-effectiveness rate N% | Total effective rate % |
| 56 | 3867.8 | 814.3 | 814.3 | 23.6 | 82.1 | 96.4 |
Claims (1)
1, a kind of gout plaster is characterized in that it is made Radix et Rhizoma Dysosmatis 8-12g, Rhizoma Dioscoreae 8-12g, Rhizoma Paridis 4-6g, Poria 8-12g, Radix Trichosanthis 8-12g by following crude drug.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100195931A CN100482260C (en) | 2006-07-08 | 2006-07-08 | Gout plaster |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100195931A CN100482260C (en) | 2006-07-08 | 2006-07-08 | Gout plaster |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1899481A CN1899481A (en) | 2007-01-24 |
| CN100482260C true CN100482260C (en) | 2009-04-29 |
Family
ID=37655592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100195931A Expired - Fee Related CN100482260C (en) | 2006-07-08 | 2006-07-08 | Gout plaster |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100482260C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101002848B (en) * | 2007-01-29 | 2011-01-19 | 张光辉 | Medicine for treating recurrent uarthritis, and its preparing method |
| CN103977207A (en) * | 2014-05-04 | 2014-08-13 | 周景龙 | Medicinal liquor for treating gout |
-
2006
- 2006-07-08 CN CNB2006100195931A patent/CN100482260C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1899481A (en) | 2007-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102078462A (en) | Asthma relieving medicament | |
| CN100482260C (en) | Gout plaster | |
| CN101912567B (en) | Chinese medicinal prescription for treating chronic myocarditis | |
| CN101002848B (en) | Medicine for treating recurrent uarthritis, and its preparing method | |
| CN103861004A (en) | Traditional Chinese medicine external application agent for treating knee osteoarthritis and nursing method | |
| CN102228559B (en) | Externally applied ointment for treating children eczema | |
| CN101961455A (en) | Traditional Chinese medicine for treating chronic colitis disease | |
| CN105106494A (en) | Traditional Chinese medicine for treating uterine fibroid | |
| CN104524458A (en) | Traditional Chinese medicinal powder for treating hepatic calculus and preparation method of powder | |
| CN104306847A (en) | Six-ingredient qi-tonifying capsule and preparation process thereof | |
| CN103330822B (en) | Chinese medicine formulation for curing chronic pharyngitis | |
| CN112791164B (en) | A kind of traditional Chinese medicine preparation for treating respiratory system infectious diseases | |
| CN102293983A (en) | Medicine for treating chronic colitis | |
| CN101983719A (en) | Novel medicament for treating lung cancer | |
| CN102895468B (en) | Traditional Chinese medicine (TCM) preparation for treating psoriasis and preparation method | |
| CN1233406C (en) | Prescription for treating cholecystolithiasis | |
| CN105079697A (en) | Traditional Chinese medicine composition for treating rheumatic heart disease and preparation method therefor | |
| CN102600315B (en) | Medicament composition used for treating rheumatoid arthritis and preparation method thereof | |
| CN103263516B (en) | Medicine for treating cholecystitis | |
| CN104001031A (en) | Medicament for treating asthma | |
| CN110354243A (en) | A kind of Chinese medicine composition that treating perianal abscess postoperative initial stage, preparation method and applications | |
| CN102151319B (en) | Hepatitis treatment medicament for oral administration | |
| CN104758346A (en) | Medicine for treating migraine, as well as preparation method and preparation of medicine | |
| CN103356829B (en) | Medicine for treating cancer of digestive tract | |
| CN118416162A (en) | Acupoint application for treating constipation with syndrome of yin deficiency and intestine dryness and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090429 Termination date: 20120708 |